Miracell to Participate in AMWC (Asia World Congress of Aesthetic Anti-Aging) 2023
Stem cell extraction system ‘Smart Mcell’ receives favorable reviews [Edaily Reporter Lee Soon-yong] Stem cell specialist Miracell (CEO Shin Hyun-soon/Shin Nuri) announced on the 10th that it participated in the AMWC ASIA & TDAC (Aesthetic Medicine World Congress ASIA & Taiwan Dermatology Aesthetic Conference 2023), held at the Taipei Convention Center in Taiwan from the 5th to the 7th, and introduced its stem cell extraction system. AMWC ASIA is a forum where aesthetic medicine doctors and industry partners gather to share insights on the latest technologies and innovative products in the fields of aesthetics, anti-aging, and cosmetic surgery. The conference attracted approximately 2,600 medical professionals from Asia, including Taiwan, and over 130 medical companies, with approximately 200 speakers. At the conference, Miracell widely promoted the excellence of its proprietary stem cell extraction system, “SMART M-CELL,” and its kits. Stem cell extraction, isolation, and concentration are achieved within 17 minutes. These autologous stem cells are ready for immediate use, with a cell viability rate of up to 99%. From anti-aging skin care to preventive care, and the treatment of conditions such as acute myocardial infarction, cartilage defects, and critical limb ischemia,Miracell has received high praise from medical professionals around the world as a biosystem that meets the needs of anti-aging medicine. Miracell has secured the core stem cell technology through 21 domestic and international cell extraction technology patents. Through Smart M-Cell, Miracell has secured National Health Technology NET (New Technology Network) and Government Innovation Product certifications, and has completed FDA registration, leading the way in the advancement of stem cell therapy and advanced regenerative medicine. CEO Shin Hyun-soon stated, “There’s a growing interest in anti-aging regenerative medicine cell therapy. After seeing our products at international conferences,we’re seeing an increasing number of medical professionals and medical group buyers visiting Korea. They observe the entire process, from stem cell extraction to treatment,using SmartMcell, or verifying the effectiveness through cell counts. Many of these patients then undergo the treatment themselves, leading to contracts.” Miracell has participated in various international conferences, including those in Europe, the US, and the Middle East. Currently, it exports SmartMcell to 30 countries,and is enjoying a smooth run in the global market. Miracell also plans to participate in IMCAS Asia, held in Bangkok, Thailand, from June 9th, to promote SmartMcell. By Lee Soon-yong